ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
-5.67%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$841M
AUM Growth
+$841M
(+17%)
Cap. Flow
+$170M
Cap. Flow
% of AUM
20.16%
Top 10 Holdings %
Top 10 Hldgs %
53.06%
Holding
33
New
8
Increased
13
Reduced
7
Closed
5
Top Buys
| 1 |
Illumina
ILMN
|
$38.4M |
| 2 |
Icon
ICLR
|
$38.3M |
| 3 |
DexCom
DXCM
|
$35.8M |
| 4 |
HealthEquity
HQY
|
$32.8M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$28M |
Top Sells
| 1 |
DaVita
DVA
|
$51.2M |
| 2 |
Envista
NVST
|
$37M |
| 3 |
Charles River Laboratories
CRL
|
$26.4M |
| 4 |
AdaptHealth
AHCO
|
$17.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
$16M |
Sector Composition
| 1 | Healthcare | 98.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Icon
ICLR
$13.8B
| $65.1M | 7.74% | 267,551 +157,551 | +143% | +$38.3M |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $53M | 6.3% | 503,744 +266,274 | +112% | +$28M |
|
3
Guardant Health
GH
$8.41B
| $47.8M | 5.69% | 722,126 +281,871 | +64% | +$18.7M |
|
4
UnitedHealth
UNH
$281B
| $45.9M | 5.46% | 90,014 +30,014 | +50% | +$15.3M |
|
|
CTLT
5
DELISTED
CATALENT, INC.
CTLT
| $43.5M | 5.18% | 392,663 +76,002 | +24% | +$8.43M |
|
|
NVRO
6
DELISTED
NEVRO CORP.
NVRO
| $40.7M | 4.84% | 562,833 +140,573 | +33% | +$10.2M |
|
7
AbbVie
ABBV
$372B
| $38.9M | 4.63% | 240,000 -10,000 | -4% | -$1.62M |
|
|
8
Illumina
ILMN
$15.8B
| $38.4M | 4.57% | +110,000 | New | +$38.4M |
|
9
Hologic
HOLX
$14.9B
| $36.9M | 4.39% | 480,000 +200,000 | +71% | +$15.4M |
|
|
10
DexCom
DXCM
$29.5B
| $35.8M | 4.26% | +70,000 | New | +$35.8M |
|
11
United Therapeutics
UTHR
$13.8B
| $34.1M | 4.06% | 190,073 +20,073 | +12% | +$3.6M |
|
12
Molina Healthcare
MOH
$9.8B
| $33.4M | 3.97% | 100,000 +2,107 | +2% | +$703K |
|
13
Acadia Healthcare
ACHC
$2.12B
| $32.9M | 3.92% | 502,640 -129,549 | -20% | -$8.49M |
|
|
14
HealthEquity
HQY
$7.72B
| $32.8M | 3.91% | +486,862 | New | +$32.8M |
|
15
ICU Medical
ICUI
$3.15B
| $30.3M | 3.61% | 136,313 +21,807 | +19% | +$4.86M |
|
16
AstraZeneca
AZN
$248B
| $25.2M | 3% | +380,000 | New | +$25.2M |
|
|
NSTG
17
DELISTED
NanoString Technologies, Inc.
NSTG
| $25.1M | 2.99% | 722,395 -27,605 | -4% | -$959K |
|
18
CONMED
CNMD
$1.68B
| $23.8M | 2.84% | 160,530 +10,753 | +7% | +$1.6M |
|
19
Surgery Partners
SGRY
$2.91B
| $22M | 2.62% | 400,000 -143,696 | -26% | -$7.91M |
|
20
Align Technology
ALGN
$10.3B
| $21.8M | 2.59% | 50,000 +10,000 | +25% | +$4.36M |
|
21
GoodRx Holdings
GDRX
$1.51B
| $21.1M | 2.51% | +1,089,677 | New | +$21.1M |
|
|
SGEN
22
DELISTED
Seagen Inc. Common Stock
SGEN
| $18.7M | 2.23% | +130,000 | New | +$18.7M |
|
23
Karyopharm Therapeutics
KPTI
$61.7M
| $14.7M | 1.75% | +2,000,000 | New | +$14.7M |
|
|
24
Envista
NVST
$3.52B
| $14.6M | 1.74% | 300,000 -760,000 | -72% | -$37M |
|
|
SLGC
25
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $14.2M | 1.69% | 1,770,000 +332,754 | +23% | +$2.67M |
|